Century Therapeutics director files initial Form 3

Century Therapeutics, Inc. director Martin Patrick Murphy filed an initial Form 3, which is a statement of beneficial ownership for insiders.

Accepted by SEC EDGAR 04/10/2026 - 05:02 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Century Therapeutics, Inc. director Martin Patrick Murphy filed an initial Form 3, which is a statement of beneficial ownership for insiders. This filing lists him as a director of Century Therapeutics but shows no reported transactions or current derivative positions in the structured data provided.

Key Figures

Buy transactions reported: 0 transactions Sell transactions reported: 0 transactions Net shares bought or sold: 0 shares

3 metrics

Buy transactions reported 0 transactions Form 3 transactionSummary buyCount

Sell transactions reported 0 transactions Form 3 transactionSummary sellCount

Net shares bought or sold 0 shares Form 3 transactionSummary netBuySellShares

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"Filed an initial Form 3, which is a statement of beneficial ownership for insiders."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"Form 3 is a statement of beneficial ownership for insiders such as directors."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"The reporting person is Martin Patrick Murphy, identified as a director."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Century Therapeutics (IPSC) Form 3 filing by Martin Patrick Murphy show?

The Form 3 for Century Therapeutics (IPSC) lists Martin Patrick Murphy as a director and serves as his initial statement of beneficial ownership. The structured data shows no reported buy or sell transactions and no derivative positions at the time of this filing.

Who is the reporting person in the Century Therapeutics (IPSC) Form 3?

The reporting person is Martin Patrick Murphy, identified as a director of Century Therapeutics, Inc. Form 3 is required when someone becomes an insider, such as a director, and it establishes a baseline record of their beneficial ownership in the company.

Does the IPSC Form 3 for Martin Patrick Murphy report any stock transactions?

The structured data for the IPSC Form 3 shows no reported transactions. All transaction-related counts, including buys, sells, exercises, gifts, and tax withholdings, are zero, indicating the filing is strictly an initial ownership statement without trading activity.

Are there any derivative securities reported in the Century Therapeutics (IPSC) Form 3?

The Form 3 data indicates no derivative securities reported for Martin Patrick Murphy. The derivative summary section is empty, and derivative transaction counts are zero, so no options, warrants, or similar instruments are listed in this filing.

What is the purpose of a Form 3 for Century Therapeutics (IPSC) insiders?

Form 3 establishes an insider’s initial beneficial ownership position when they become a director, officer, or major shareholder. For Century Therapeutics (IPSC), it records that Martin Patrick Murphy is a director and sets a baseline for any future Form 4 or Form 5 updates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Murphy Martin Patrick

(Last) (First) (Middle)

C/O CENTURY THERAPEUTICS, INC.

25 N 38TH STREET, 11TH FLOOR

(Street)

PHILADELPHIA PENNSYLVANIA 19104

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/09/2025

3. Issuer Name and Ticker or Trading Symbol
Century Therapeutics, Inc. [ IPSC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Douglas Carr, Attorney-in-Fact	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)